![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Luminex Corporation | NASDAQ:LMNX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 36.99 | 36.94 | 36.98 | 0 | 01:00:00 |
AUSTIN, Texas, Feb. 8, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the first quarter of 2019 of $0.06 per share of common stock payable on April 11, 2019 to stockholders of record as of the close of business March 21, 2019.
About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.
Contact:
Harriss Currie
Senior Vice President and Chief Financial Officer
512-219-8020
hcurrie@luminexcorp.com
David Carey
Investor Relations
Lazar Partners
212-867-1768
dcarey@lazarpartners.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-declares-first-quarter-cash-dividend-300792516.html
SOURCE Luminex Corporation
Copyright 2019 PR Newswire
1 Year Luminex Chart |
1 Month Luminex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions